---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-008786"
form_type: "8-K"
ticker: "TVGN"
cik: "0001860871"
company_name: "Tevogen Bio Holdings Inc."
filed_at: "2026-03-04T23:59:59+00:00"
generated_at: "2026-05-15T21:49:23.554770+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tevogen Bio announces 1-for-50 reverse stock split effective March 6, 2026 to regain Nasdaq compliance

## Summary
- Reverse stock split ratio 1-for-50; effective 12:01 a.m. March 6, 2026.
- Pre-split shares outstanding: 202,416,556 as of March 3, 2026.
- Directors and executive officers beneficially own >70% of common stock.
- No fractional shares issued; cash paid in lieu based on closing price day before effective date.
- Authorized shares unchanged at 800M; symbol TVGN remains; new CUSIP 88165K200.

## SEC filing metadata
- accession: 0001493152-26-008786
- form_type: 8-K
- ticker: TVGN
- cik: 0001860871
- company_name: Tevogen Bio Holdings Inc.
- filed_at: 2026-03-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-008786
- JSON: https://secwatch.observer/filing/0001493152-26-008786.json
- Plain text: https://secwatch.observer/filing/0001493152-26-008786.txt

## Source-grounded claims
- claim_id: 189c504cb95c01ff7e449b7d59552998297819a7
  claim: Tevogen Bio Holdings Inc.: Effected a 1-for-50 reverse stock split by filing a Certificate of Amendment to the Certificate of Incorporation, effective March 6, 2026 (effective 2026-03-06).
  evidence_excerpt: On March 3, 2026, Tevogen Bio Holdings Inc. (the “Company”) filed a Certificate of Amendment to its Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split of the issued and outstanding common stock, par value $0.0001 per share (the “Common Stock”), of the Company (the “Reverse Stock Split”), to be effective as of March 6, 2026 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860871/000149315226008786/0001493152-26-008786-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.